Researchers unveiled a generative AI model capable of atomic-scale prediction of protein–protein interactions, aiming to improve how scientists identify and engineer biologically relevant binding interfaces. The work underscores that protein interaction mapping remains central for many therapeutic modalities, including antibody-based treatments and protein replacement approaches. The approach is positioned to assist both discovery and design by producing interaction predictions at higher resolution than traditional workflows. If robust across diverse protein pairs, this could shorten iteration cycles for target validation and lead optimization. While the report focuses on the technical capability, the practical impact for biotech will hinge on whether the model’s predictions reliably translate into experimentally testable candidates and whether it can be integrated into drug discovery pipelines.